Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Lidocaine for Nasogastric Tube Insertion
NCT07103915Completed
- Sponsor
- Ankara City Hospital
- Start
- Nov 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by Ankara City Hospital. Primary endpoints: Procedure success rate (first-pass success) and Pain during insertion. Started Nov 2023; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT07103915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07103915.